Home Cart Sign in  
Chemical Structure| 618913-30-7 Chemical Structure| 618913-30-7

Structure of AZD5904
CAS No.: 618913-30-7

Chemical Structure| 618913-30-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

AZD5904 is a potent and irreversible MPO inhibitor with IC50 value of 140nM. Continuous subcutaneous AZD5904 infusion during the 2 week selectively blocked HFD (high-fat diet)'s microvascular effect.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of AZD5904

CAS No. :618913-30-7
Formula : C10H12N4O2S
M.W : 252.29
SMILES Code : O=C1NC(N(C[C@@H]2OCCC2)C3=C1N=CN3)=S
MDL No. :MFCD31619279
InChI Key :RSPDBEVKURKEII-ZCFIWIBFSA-N
Pubchem ID :10264211

Safety of AZD5904

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
IPSC-CMs (induced pluripotent stem cell-derived cardiomyocytes) 10 µM 1 week To evaluate the long-term effects of AZD5904 on calcium signaling and contractility in HCM-CMs. Results showed that AZD5904 significantly shortened the half-width and decay times of calcium transients in HCM-CMs, alleviating the cardiomyocyte relaxation defect. PMC8803077

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Melanoma model Intraperitoneal injection 180 µmol/kg Once daily for 14 days To evaluate the therapeutic effect of AZD5904 in combination with immune checkpoint therapy (ICT) for melanoma. Results showed that AZD5904 combined with ICT significantly improved long-term survival rates, achieving 100% long-term survival in some models. PMC9944647

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.96mL

0.79mL

0.40mL

19.82mL

3.96mL

1.98mL

39.64mL

7.93mL

3.96mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories